πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 255 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8816046

Compositions and methods for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8808710

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735358

Methods for treating cancer by regulation of tumor necrosis factor-alpha

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8727775

Dimer acid-derived dimethacrylates and use in dental restorative compositions

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8725266

Method for stimulating retinal response using photoactive devices

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715649

Compositions and methods of use for alpha-1 antitrypsin having no significant serine prote

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703140

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697628

Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685926

Compositions and method for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673300

Therapeutic compositions and methods for the prevention of autoimmune diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8652475

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8642614

Toll-like receptor modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8637239

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8623917

Uses of prostacyclin analogs

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8598133

Methods for treating pain

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8575170

Flurbiprofen analogs and methods of use in treating cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8569225

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563515

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8557764

Methods of modulating immune function

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8540997

Complement receptor 1 and 2 fusion proteins

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8524678

Method for delivering genes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8454977

Non-toxic biofilm inhibitor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8444991

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted